Amgen, Inc. vs Applied Digital Corporation — how do they compare? Amgen, Inc. trades at $412.21 (market cap $224.14B), while Applied Digital Corporation trades at $31.43 (market cap $8.55B). The key difference: Amgen, Inc. is far larger — about 26.2× Applied Digital Corporation's market cap, and Amgen, Inc. pays a 2.43% dividend while Applied Digital Corporation pays none. Which is the better fit depends on your goals.
| AMGN | APLD | |
|---|---|---|
Market Cap | $224.14B | $8.55B |
Sector | Health | Technology |
52-Week High | $417.20 | $49.65 |
52-Week Low | $271.18 | $13.89 |
Enterprise Value | $267.45B | $12.06B |
Dividend Yield | 2.43% | — |
Trailing returns across standard periods
Latest headlines on both assets
Amgen is a leader in biotechnology-based human therapeutics, with historical expertise in renal disease and cancer supportive-care products. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). Amgen's biosimilar portfolio includes Mvasi (biosimilar Avastin), Kanjinti (biosimilar Herceptin), and Amgevita (biosimilar Humira).
Read more on AMGN →Applied Digital provides high-performance computing (HPC) infrastructure and cloud services. It designs and operates data centers tailored for AI, machine learning, and other intensive digital workloads across North America.
Read more on APLD →